semaglutide tampa florida WEIGHT LOSS SHOT - Updated July 2026 - 10 Photos - 3414 W Bay To Bay Blvd, Tampa, - Weight Loss Centers - Phone Number Benefits of Semaglutide in Tampa

The company claimed it contained the same active ingredient (semaglutide) found in Wegovy and Ozempic

PLoS One 11 , e0148827 (2016)

doi: 10.1016/j.copbio.2020.08.009

Showed 28.7% weight loss and significant osteoarthritis pain reduction

Ozgoli G, Goli M, Moattar F

Tirzepatide (Mounjaro/Zepbound) Timeline Phase 3 trials began: 2019 (SURPASS program for diabetes) FDA approval (Mounjaro for diabetes): May 2022 Commercial availability: June 2022, initial supply constraints Zepbound (obesity indication) Phase 3: 2020-2022 (SURMOUNT program) Zepbound FDA approval: November 2023 Zepbound commercial launch: December 2023, immediate shortages Stable widespread availability: Still not fully stable as of early 2026